Search For "dru"
Drug treatment could improve immunotherapy's effectiveness in cancer patie
Updated : 5 years, 11 months ago IST
California [USA], July 9 (ANI): While immunotherapy, a treatment that uses the human body's immune system to recognize, attack and kill tumour cells, has given hope to people across the globe, it fails in a significant proportion of cancer patients.
Read More
Ludhiana: Two sisters held in drug smuggling case
Updated : 5 years, 11 months ago IST
Ludhiana (Punjab) [India], July 8 (ANI): Two sisters were arrested by the Special Task Force (STF) in Ludhiana on Wednesday in an alleged drug smuggling case. Police said the duo had 1.2 kilograms of heroin when they were caught.
Read More
COVID19: Top drug regulator directs states drug controller to be vigilant
Updated : 5 years, 11 months ago IST
New Delhi [India], July 7 (ANI): The country's top drug regulator has directed all drug controller in the States and Union Territories to keep strict vigil to prevent the black marketing and sale of the anti-drug Remdesivir injection above the minimum retail price (MRP).
Read More
Indian pharma compliance standards improving, regulatory risks here to sta
Updated : 5 years, 11 months ago IST
Mumbai (Maharashtra) [India], July 7 (ANI): Indian pharmaceutical companies have built a strong abbreviated new drug application (ANDA) pipeline since FY12 through scaling-up of investments in R&D but this will increase the inspection intensity, India Ratings and Research (Ind-Ra) said o
Read More
J-K: Police bust drug racket in Samba, 2 arrested
Updated : 5 years, 11 months ago IST
Samba (Jammu and Kashmir) [India], July 7 (ANI): The Jammu and Kashmir Police on Tuesday arrested two drug peddlers in Samba and seized large quantities of cough syrup bottles and pain killer capsules from their possession.
Read More
Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per via
Updated : 5 years, 11 months ago IST
Bengaluru (Karnataka) [India], July 7 (ANI): Global pharmaceutical major Mylan has got approval for its remdesivir from the Drug Controller General of India (DCGI) and will launch a generic version of Gilead Sciences' COVID-19 anti-viral in the country at Rs 4,800 for 100 mg/vial.
Read More
Four smugglers held, drugs and cash recovered in Visakhapatnam
Updated : 5 years, 11 months ago IST
Visakhapatnam (Andhra Pradesh) [India], July 6 (ANI): Visakhapatnam Police on Sunday raided a house in city's Fourth Town police station limits following which four alleged drug smugglers have been arrested. The Visakhapatnam Special Task Force Police also claimed to have recovered 61 LSD b
Read More
WHO halts hydroxychloroquine and combination of HIV drug trials among hosp
Updated : 5 years, 11 months ago IST
Geneva [Switzerland], July 5 (ANI) The World Health Organisation on Saturday has halted its trials of the malaria drug hydroxychloroquine and combination of HIV drug lopinavir/ritonavir for the treatment of hospitalised COVID-19 patients after they failed to reduce the death rate, Al Jaze
Read More
Popular chemotherapy drug likely to be less effective in overweight, obese
Updated : 5 years, 11 months ago IST
Brussels [Belgium], July 4 (ANI): Treatment with docetaxel, a common chemotherapy drug, might have lesser benefits for breast cancer patients who are overweight or obese, according to new research.
Read More
Health ministry revises remdesivir dosage for COVID-19 patients
Updated : 5 years, 11 months ago IST
New Delhi [India], July 4 (ANI): The Union Health Ministry on Friday has revised the dosage of the antiviral drug--remdesivir, being administered to hospitalized COVID-19 patients from the earlier six-days to five-day treatment course.
Read More
Drug discovery hackathon can yield COVID-19 solution
Updated : 5 years, 11 months ago IST
New Delhi [India], July 3 (ANI): The drug discovery hackathon, a joint initiative of All India Council for Technical Education (AICTE) and Council of Scientific and Industrial Research (CSIR), can yield to some novel solution for COVID-19, said Shekhar Mande, Director-General, CSIR.
Read More
DCGI permits human clinical trials for COVID-19 vaccine of Zydus Cadila
Updated : 5 years, 11 months ago IST
New Delhi [India], July 3 (ANI): The Drug Controller General of India (DCGI) on Thursday granted permission to pharma giant Zydus Cadila to conduct phase I and phase II human clinical trials for COVID -19 vaccine, a top government official told ANI.
Read More